<DOC>
	<DOCNO>NCT01840475</DOCNO>
	<brief_summary>Botulinum toxin A ( BoNT-A ) effective safe alleviate post-stroke spasticity reduce burden associate symptom . The hypothesis non-interventional study arm spasticity ( AS-NIS early BIRD ) significant difference naïve pre-treated patient . The patient divide sub-groups accord time interval occurrence stroke start treatment ( early , medium late start treatment accord first third quartile time distribution ) . It hypothesize `` early '' start treatment group reduce modified Ashworth scale ( MAS ) elbow wrist flexor compare `` late '' start treatment group .</brief_summary>
	<brief_title>Arm Spasticity - Non-Interventional Study Early BIRD ( BoNT Treatment : Initial Repeated Documentation ) AS-NIS Early BIRD</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Written inform consent prior data collection Hemiparesis clinically relevant upper limb poststroke spasticity Treated Dysport® intention treat Dysport® accord local SmPC BoNT naïve pretreated BoNT product Recurrent stroke Sensitivity Dysport® excipients contraindication give local SmPC Dysport®</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>